BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36686837)

  • 1. Case report: Imaging findings of true thymic hyperplasia at
    Ren J; Fu Z; Zhao Y
    Front Oncol; 2022; 12():1077777. PubMed ID: 36686837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of thymic masses using (18)F-FDG PET-CT.
    Kumar A; Regmi SK; Dutta R; Kumar R; Gupta SD; Das P; Halanaik D; Jindal T
    Ann Nucl Med; 2009 Aug; 23(6):569-77. PubMed ID: 19585212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
    El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing thymic cysts from low-risk thymomas via [
    Choi S; Kim YI; Han S; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
    EJNMMI Res; 2024 May; 14(1):45. PubMed ID: 38702532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning.
    Travaini LL; Petralia G; Trifirò G; Ravasi L; Galetta D; Carbone G; Falcini F; Spaggiari L; Bellomi M; Paganelli G
    Lung Cancer; 2008 Sep; 61(3):362-8. PubMed ID: 18358558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
    Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Utility of PET CT in Thymic Tumours with Emphasis on 68Ga-DOTATATE PET CT in Thymic Neuroendocrine Tumour - Experience at a Tertiary Level Hospital in India.
    Hephzibah J; Shanthly N; Oommen R
    J Clin Diagn Res; 2014 Sep; 8(9):QC01-3. PubMed ID: 25386498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic thymic uptake of 18F-FDG in children and young adults: a PET/CT evaluation of incidence, patterns, and relationship to treatment.
    Jerushalmi J; Frenkel A; Bar-Shalom R; Khoury J; Israel O
    J Nucl Med; 2009 Jun; 50(6):849-53. PubMed ID: 19443604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report.
    Liu RS; Yeh SH; Huang MH; Wang LS; Chu LS; Chang CP; Chu YK; Wu LC
    Eur J Nucl Med; 1995 Dec; 22(12):1402-7. PubMed ID: 8586085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors.
    Liu Y
    Nucl Med Commun; 2011 Jul; 32(7):554-62. PubMed ID: 21403583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Characterization of Anterior Mediastinal Masses by
    Koç ZP; Özcan PP; Ayan E; Bozdoğan Arpacı R
    Mol Imaging Radionucl Ther; 2020 Oct; 29(3):105-111. PubMed ID: 33094573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG-PET/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors.
    Ito T; Suzuki H; Sakairi Y; Wada H; Nakajima T; Yoshino I
    Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):274-281. PubMed ID: 32734427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of
    Li Y; Li Y; Huang Y; Wu X; Yang Z; Wu C; Jiang L
    Ann Nucl Med; 2021 Sep; 35(9):1048-1057. PubMed ID: 34101153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of
    Al-Ibraheem A; Hirmas N; Fanti S; Paez D; Abuhijla F; Al-Rimawi D; Al-Rasheed U; Abdeljalil R; Hawari F; Alrabi K; Mansour A
    BMC Med Imaging; 2021 Mar; 21(1):49. PubMed ID: 33731050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic ability of
    Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
    Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic values of 2-[
    Han S; Kim YI; Oh JS; Seo SY; Park MJ; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
    Eur Radiol; 2022 Feb; 32(2):1173-1183. PubMed ID: 34448035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (18)F-FDG PET/CT is Useful for Pretreatment Assessment of the Histopathologic Type of Thymic Epithelial Tumors.
    Kim JY; Kim HO; Kim JS; Moon DH; Kim YH; Kim DK; Park SI; Park YS; Ryu JS
    Nucl Med Mol Imaging; 2010 Sep; 44(3):177-84. PubMed ID: 24899947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.